Atopic Dermatitis

FDA approves dupilumab for atopic dermatitis treatment in pediatrics

May 26, 2020

The US Food and Drug Administration has approved dupilumab (Dupixent, Sanofi and Regeneron) for the treatment of moderate-to-severe atopic dermatitis in children aged 6 to 11 years.

Postpartum depression linked to atopic dermatitis in children

February 06, 2020

Postpartum depression has a number of profound effects. A new study indicates that postpartum depression could increase the risk of atopic dermatitis, especially at ages 5 and 9 years.

How treating food allergies and AD has changed

September 27, 2019

Food allergies are a hot topic on the playground, at schools, and in pediatric offices. Parents of children with eczema or atopic dermatitis (AD) often have a lot of questions regarding the connection between eczema, exposure to common food allergens, and the development of or exacerbation of AD. There are many of the complex questions that clinicians must answer when evaluating pediatric patients with AD.